Clinical Trials Search
Clinical Trial 18396
Cancer Type: Gastrointestinal Tumor
Study Type: Treatment
Phase of Study: Phase III
A Phase III Clinical Trial Evaluating TheraSphere® in Patients with Metastatic Colorectal Carcinoma of the Liver who have Failed First Line Chemotherapy
The effectiveness and safety of TheraSphere will be evaluated in patients with colorectal cancer with metastases in the liver, who are scheduled to receive second line chemotherapy. All patients receive the standard of care chemotherapy with or without the addition of TheraSphere.
The objective of this study is to evaluate the efficacy and safety of TheraSphere in patients with metastatic colorectal cancer of the liver who have progressed with first line chemotherapy.